Ma TM, Czernin J, Felix C, Alano R, et al. LUNAR: a randomized phase 2 study of (177) Lutetium-PSMA neoadjuvant to ablative radiotherapy for oligorecurrent prostate cancer (clinical trial protocol). BJU Int 2023 Feb 16. doi: 10.1111/bju.15988.
PMID: 36797449